Response to Harrison et al. ‘Clinically relevant differences between BCSH and WHO diagnostic criteria for ET'

Documenti analoghi

• Clinical impact of bone marrow morphology for the diagnosis of essential thrombocythemia: comparison between the BCSH and the WHO criteria
  di: Gisslinger, H, et al.
  Pubblicazione: (2016)
• Erratum: Clinical impact of bone marrow morphology for the diagnosis of essential thrombocythemia: comparison between the BCSH and the WHO criteria
  di: Gisslinger, H, et al.
  Pubblicazione: (2017)
• Essential thrombocythemia vs. pre-fibrotic/early primary myelofibrosis: discrimination by laboratory and clinical data
  di: Schalling, Martin, et al.
  Pubblicazione: (2017)
• The 2016 WHO classification and diagnostic criteria for myeloproliferative neoplasms: document summary and in-depth discussion
  di: Barbui, Tiziano, et al.
  Pubblicazione: (2018)
• Diagnostic criteria for HPV infection classification: a comment on Wen et al.
  di: Elian Analí Camero-Ortiz, et al.
  Pubblicazione: (2025-11-01)